Management of Neurologic Diseases

  • Authors: David M. Simpson, MD; Jessica Robinson-Papp, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/1/16 (What's New)

Summary

  • Optimal management of patients with CD4+ cell counts < 200 cells/mm3 and negative serum toxoplasmosis antibodies is unclear
    • Cerebral toxoplasmosis without detectable serum antibodies is uncommon[Sadler 1998]
    • Some clinicians may choose to treat such patients empirically for toxoplasmosis, given the risks of brain biopsy

Action required